Guardant Health vs InnovAge
InnovAge reported revenue of $990 million in fiscal 2026, about the same as Guardant Health's $982 million in fiscal 2025. Guardant Health's revenue grew 32.9% in its latest year, and InnovAge's grew 15.9%. Guardant Health had an operating margin of -44.5%, against 0.3% at InnovAge. Free cash flow was −$233 million at Guardant Health and $50 million at InnovAge. Their fiscal years end in different months (December 31 and June 30), so the periods don't line up exactly.
Side by side
| Guardant Health | InnovAge | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2026, Jun 30, 2026 |
| Revenue | $982M | $990M |
| Revenue growth | 32.9% | 15.9% |
| Revenue growth a year, last 5 years | 27.9% | 9.2% |
| Gross margin | 64.5% | 23.0% |
| Operating margin | −44.5% | 0.3% |
| Net margin | −42.4% | −0.3% |
| Free cash flow | −$233M | $50M |
| Free cash flow margin | −23.7% | 5.1% |
| Return on capital | −188.8% | 0.7% |
| Net debt to EBITDA | — | −3.3x |
| Dividends and buybacks | $45M | $0M |
| Change in diluted share count | 2.1% | 0.2% |
| Last close | $145.59 | $8.91 |
| P/E at the last close | — | 148.5× |
| Insider trades, last 12 months | bought $78,456, sold $173.5 million | sold $92.7 million |
| Piotroski F-score | 4 of 9 | 6 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Guardant HealthInnovAge
Operating margin
Percent of revenue
Guardant HealthInnovAge
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Guardant HealthInnovAge
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Guardant Health and InnovAge pages.